Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-22-006159

CEO acquired 86,655 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Neill Gilmore Neil CEO 2022-06-02 Grant or award +86,655 86,655 D
Derivatives
O'Neill Gilmore Neil CEO 2022-06-02 Grant or award · Stock Option (right to buy) +950,209 950,209 D
Loading xslF345X03/form4-06062022_010612.xml…